|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 724.20 GBX | -3.70% |
|
+2.67% | -20.26% |
| 07-17 | WINNERS & LOSERS: Vega ups Vodafone stake; GSK drug trial disappoints | AN |
| 07-13 | SBG Securities Cuts Mondi's PT, Maintains Buy Rating | MT |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
 | 9.06 | +6.56% | 12 | ||||||
| 55.04 | +27.57% | 14 | ||||||
| 246.2 | +7.78% | 10 | ||||||
| 42.73 | +17.87% | 11 | ||||||
| 16.48 | +12.52% | 13 | ||||||
| 62 | +13.57% | 9 | ||||||
| 38.59 | +50.97% | 4 | ||||||
| 7.986 | +27.71% | 9 | ||||||
| 28.53 | -5.69% | 18 | ||||||
| 34.2 | +28.09% | 10 | ||||||
| 11.8 | +8.86% | 11 | ||||||
| 1,656.67 | +15.81% | 6 | ||||||
| 4.067 | +19.26% | 3 | ||||||
| 94 | +15.91% | 3 | ||||||
| 80.83 | +16.81% | 6 | ||||||
| 2.96 | +8.66% | 5 | ||||||
| - | - | 13 | -12.99% | 1 | ||||
| Average | 141.42 | +15.25% | 9 | ||||||
| Weighted average by Cap. | 110.87 | +17.64% | 11 |
- Stock Market
- Stocks
- MNDI Stock
- Sector Mondi plc
- Sector consensus
Select your edition
All financial news and data tailored to specific country editions
